Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Peritumoral Injection of Immature Dendritic Cells to Irradiated Skin Metastases of Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating peritumoral injections of immature dendritic cells into irradiated skin metastases from solid tumors h…
-
CLINICAL_TRIALS trial_result · 2015-04-20Clinical Trial Update: Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6) [Phase 1]
Phase 1 update on weekly dosing of SCH 727965 in patients with advanced cancer, including solid tumors, non-Hodgkin lymphoma, multiple myelo…
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies [Phase 1]
Open-label Phase 1 dose-escalation study of 4SC-205, an Eg5 kinesin-spindle inhibitor, in patients with advanced solid tumors and malignant …
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors [Phase 1]
This Phase 1 trial evaluated laboratory-treated autologous lymphocytes with aldesleukin and sargramostim (GM-CSF) for advanced solid tumors;…
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid Malignancies [Phase 1]
This Phase 1 study evaluates Nesvacumab (REGN910/SAR307746) in combination with aflibercept (Ziv-aflibercept) in patients with advanced soli…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Dose-finding Adaptive Phase I/IIa Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of IPP-204106N on Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports completion of an adaptive dose-finding Phase I/IIa study evaluating IPP-204106N in patients with advanced…
-
CLINICAL_TRIALS trial_result · 2015-01-30Clinical Trial Update: An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate [Phase 1]
Open-label Phase 1 pharmacokinetics study of omacetaxine mepesuccinate; the trial completed, investigating PK in hematologic malignancies an…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors [Phase 1]
Phase 1 safety and pharmacokinetic study of CVX-060 in patients with advanced solid tumors has completed and results are posted.
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: To Determine Maximum Tolerated Dose of BAY79-4620 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial completed to determine the maximum tolerated dose of BAY79-4620 in patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Pharmacokinetic Study of Carboplatin in Pediatric Hematopoietic Stem Cell Transplantation [Phase 2]
This document provides an update on a Phase 2 pharmacokinetic study of carboplatin in pediatric patients undergoing hematopoietic stem cell …
-
CLINICAL_TRIALS trial_result · 2015-01-09Clinical Trial Update: Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia [Phase 1]
Phase I study evaluating bevacizumab plus sorafenib with low-dose cyclophosphamide in patients with refractory solid tumors and leukemia has…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Study of MGCD0103 Given Three-Times Weekly in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of MGCD0103 (mocetinostat) given three times weekly in patients with advanced solid tumors or Non-Hodgkin's lymphoma has compl…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid Tumors [Phase 1]
This Phase 1 trial update reports the safety and pharmacokinetic profile of daily oral SAR245408 in patients with solid tumors.
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: The Treatment of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid Tumors [Phase 1]
This Phase 1 trial evaluates the safety and preliminary activity of the combination of lapatinib and sorafenib in patients with advanced ref…
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib [Phase 1]
Phase I study assessing weekly and every-3-week Abraxane in combination with Vandetanib for solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Safety Study of a Cell Penetrating Peptide (p28) to Treat Solid Tumors That Resist Standard Methods of Treatment [Phase 1]
Phase 1 safety study evaluating the cell-penetrating peptide p28 for solid tumors resistant to standard therapies has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-23Clinical Trial Update: INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease [Phase 1]
A Phase 1 pediatric trial of INCB18424 (ruxolitinib) in relapsed or refractory solid tumors, leukemia, or myeloproliferative disorders has c…
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: Phase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II) [Phase 1, Phase 2]
This is a Phase I/II trial evaluating AZD8931 in combination with Paclitaxel for advanced solid tumors and advanced breast cancer. The study…
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors [Phase 1]
A Phase 1 clinical trial of an oral PI3K/mTOR inhibitor in patients with advanced refractory solid tumors has been suspended.
-
CLINICAL_TRIALS trial_result · 2014-09-23Clinical Trial Update: AMG 386 Drug-Drug Interaction Study With Paclitaxel [Phase 1]
Phase 1 trial update evaluating the drug-drug interaction of AMG 386 with paclitaxel in patients with advanced solid tumors; the study statu…
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors Including Lymphomas [Phase 1]
The document reports the completion of a Phase 1 study evaluating GO-203-2C given intravenously in patients with advanced solid tumors (incl…
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: A Study of MM-111 in Patients With Advanced, Refractory Her2 Amplified, Heregulin Positive Cancers [Phase 1]
Phase 1 study of MM-111 in advanced, refractory HER2-amplified, heregulin-positive cancers has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2014-08-08Clinical Trial Update: BI 2536 BS in Patients With Advanced Solid Tumours and Repeated Administration in Patients With Clinical Benefit [Phase 1]
Phase 1 trial update of BI-2536 in patients with advanced solid tumors. The study has completed after repeated administration in patients wh…
-
CLINICAL_TRIALS trial_result · 2014-08-07Clinical Trial Update: Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors [Phase 1]
Phase 1 clinical trial evaluating valproic acid in children with recurrent or refractory solid tumors or central nervous system tumors; the …
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer [Phase 1]
This document reports the completion of a Phase 1, open-label, dose-escalation study of ANG1005 in patients with advanced solid tumors, with…